These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25938799)

  • 21. Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity.
    Zhou P; Cowled C; Todd S; Crameri G; Virtue ER; Marsh GA; Klein R; Shi Z; Wang LF; Baker ML
    J Immunol; 2011 Mar; 186(5):3138-47. PubMed ID: 21278349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpesviruses and the Type III Interferon System.
    Yin Y; Favoreel HW
    Virol Sin; 2021 Aug; 36(4):577-587. PubMed ID: 33400088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I and type II interferons upregulate functional type I interleukin-1 receptor in a human fibroblast cell line TIG-1.
    Takii T; Niki N; Yang D; Kimura H; Ito A; Hayashi H; Onozaki K
    J Interferon Cytokine Res; 1995 Dec; 15(12):1065-73. PubMed ID: 8746788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chicken IFN Kappa: A Novel Cytokine with Antiviral Activities.
    Santhakumar D; Iqbal M; Nair V; Munir M
    Sci Rep; 2017 Jun; 7(1):2719. PubMed ID: 28578423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular genetic aspects of interferon induction and antiviral action].
    Bazhan SI; Belova OE
    Vestn Ross Akad Med Nauk; 1998; (3):18-24. PubMed ID: 9608271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type III IFNs: Beyond antiviral protection.
    Kotenko SV; Rivera A; Parker D; Durbin JE
    Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What have we learned from the IL28 receptor knockout mouse?
    Mordstein M; Michiels T; Staeheli P
    J Interferon Cytokine Res; 2010 Aug; 30(8):579-84. PubMed ID: 20649452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of interferon-induced antiviral states: contrasting profiles of decay in response to the removal of MuIFN-alpha, MuIFN-beta and MuIFN-gamma.
    Ramamurthy V; Fleischmann WR
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1645-52. PubMed ID: 3016159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection.
    Li SF; Gong MJ; Zhao FR; Shao JJ; Xie YL; Zhang YG; Chang HY
    Cell Physiol Biochem; 2018; 51(5):2377-2396. PubMed ID: 30537741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells.
    Pervolaraki K; Guo C; Albrecht D; Boulant S; Stanifer ML
    J Interferon Cytokine Res; 2019 Oct; 39(10):650-660. PubMed ID: 31199715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion.
    Sekellick MJ; Lowenthal JW; O'Neil TE; Marcus PI
    J Interferon Cytokine Res; 1998 Jun; 18(6):407-14. PubMed ID: 9660248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus.
    Huang J; Smirnov SV; Lewis-Antes A; Balan M; Li W; Tang S; Silke GV; Pütz MM; Smith GL; Kotenko SV
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9822-7. PubMed ID: 17517620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
    Atreya PL; Kulkarni S
    Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential interferon pathway gene expression patterns in Rhabdomyosarcoma cells during Enterovirus 71 or Coxsackievirus A16 infection.
    Zhang W; Zhang L; Wu Z; Tien P
    Biochem Biophys Res Commun; 2014 May; 447(3):550-5. PubMed ID: 24735544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interferon response to bacterial and viral infections.
    Pietras EM; Saha SK; Cheng G
    J Endotoxin Res; 2006; 12(4):246-50. PubMed ID: 16953977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression and activity of the porcine type I interferon family.
    Sang Y; Rowland RR; Hesse RA; Blecha F
    Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.